Minerva Endocrinologica 2009 December;34(4)

ORIGINAL ARTICLES  

Minerva Endocrinologica 2009 December;34(4):273-9

Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients

Mirzaei K., Hossein-Nezhad A., Javad Hosseinzadeh-Attar M., Jafari N., Najmafshar A., Mohammadzadeh N., Larijani B.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Endocrinologica 2009 December;34(4):281-8

Thyroid carcinoma risk in patients with hyperthyroidism and role of preoperative cytology in diagnosis

Gul K., Di.Ri.Koc A., Ki.Yak G., Ersoy P. E., Ugras N. S., Ozdemi D., Ersoy R., Cakir B.

Abstract PDF

ORIGINAL ARTICLES  

Minerva Endocrinologica 2009 December;34(4):289-94

Can we use ionized calcium in the evaluation of post-thyroidectomy hypocalcemia?

Del Rio P., Arcuri M. F., Cataldo S., Palladino S., Sianesi M.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2009 December;34(4):295-10

Genetic risk of breast cancer

Nasir A., Shackelford R. E., Anwar F., Yeatman T. J.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2009 December;34(4):311-24

Treatment of early breast cancer

Rao R., Wiechmann L.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2009 December;34(4):325-32

Male osteoporosis

Rocchietti March M., Pisani D., Aliberti G.

Abstract PDF

REVIEWS  

Minerva Endocrinologica 2009 December;34(4):333-8

Aliskiren: a new inhibitor of renin-angiotensin-aldosterone system activity

Dalla Vestra M., Simioni N., Masiero A.

Abstract PDF